SEC 13F Intelligence

Worth Venture Partners, LLC / BCRX

Worth Venture Partners, LLC’s Biocryst Pharmaceuticals Inc Position

Does Worth Venture Partners, LLC own Biocryst Pharmaceuticals Inc (BCRX)? Not currently — the last reported position was 39.0K shares worth $198,120 in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$198,120
Q1 2024
Shares
39.0K
% of Portfolio
+1.32%
Quarters Held
1
position exited

Position History BCRX

Reported value by quarter
Q1 ’24: $198,120Q1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202439.0K$198,120+1.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Worth Venture Partners, LLC’s full portfolio or all institutional holders of BCRX.